Addressing The Evolving Needs Of Variable Drug Delivery Regimens

By Temitope Sodunke, Ph.D., Strategic Innovation Leader, BD Medical – Pharmaceutical Systems

The pharmaceutical industry is rapidly evolving and experiencing a diverse set of competing challenges. These challenges include a changing healthcare landscape and transition of care out of the traditional clinical settings to alternative sites, including patients’ homes. Several biologic blockbusters have expiring patents, increasing pressure on pharmaceutical companies to maximise revenue and stay ahead of competition. There is also an emergence of biosimilars fuelling the need for effective drug product differentiation. Lastly, patient demands and expectations are changing as they seek a greater role in their own care.

To address these challenges, innovative pharmaceutical companies continue to advance their clinical development pipelines to develop new and more sophisticated biologics. Other companies are revisiting their lifecycle management strategies and general market entry approaches to compete more successfully (identifying new use cases, alternative delivery formats, and promoting value-added services that boost patient engagement). Some companies are riding new technology trends towards a more cost-effective and patient-centric healthcare delivery model.

In this article, Temitope Sodunke, PhD, Strategic Innovation Leader, BD Medical – Pharmaceutical Systems, introduces the BD Evolve™ On-body Injector and describes how the device is designed specifically to address the rapidly evolving needs of the pharma industry and meet patient requirements.